OLMA
Olema Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$851.64M
P/E Ratio
—
EPS
$-2.03
Beta
2.00
52W High
$36.26
52W Low
$3.90
50-Day MA
$14.07
200-Day MA
$16.96
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Olema Pharmaceuticals Inc
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company is headquartered in San Francisco, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-191.33M |
| Operating Margin | 0.00% |
| Return on Equity | -42.90% |
| Return on Assets | -25.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $5.88 |
| Price-to-Book | 1.77 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -3.33 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $87.35M |
| Float | $59.72M |
| % Insiders | 1.80% |
| % Institutions | 119.43% |
Historical Volatility
HV 10-Day
95.07%
HV 20-Day
78.76%
HV 30-Day
68.94%
HV 60-Day
61.62%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($41.36 target)
2
Strong Buy10
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026